Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001218167 | SCV001390039 | uncertain significance | Neuroblastoma, susceptibility to, 3 | 2024-11-21 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the ALK mRNA. It is expected to extend the length of the ALK protein by 8 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALK-related conditions. ClinVar contains an entry for this variant (Variation ID: 947158). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003442779 | SCV004168473 | uncertain significance | not provided | 2023-04-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Normal stop codon changed to a leucine codon, leading to the addition of 8 amino acids at the C-terminus; Has not been previously published as pathogenic or benign to our knowledge |